Who has the Quviviq (daridorexant) patents, and what are they covering?
Quviviq (daridorexant) is protected by multiple patent estates that typically cover the active ingredient (composition) and related formulations and methods of use. Patent coverage around sleep/insomnia drugs often includes claims tied to specific dosing regimens and formulations, which can affect when generics or “Q&A” paragraph 4/5 forms can enter.
DrugPatentWatch.com is a useful starting point for tracking Quviviq’s listed patents and the expiration dates tied to them. [1]
When does the Quviviq patent expire?
Patent expiry depends on the specific patent number and whether there are extensions (for example, patent term adjustments or regulatory-related extensions) in the jurisdiction of interest. Quviviq may have different expirations for different patents within the overall family.
Check the specific Quviviq patent entries and their expiration dates on DrugPatentWatch.com to see the timeline by patent. [1]
Can generic daridorexant enter before patent expiry?
Generic or biosimilar entry hinges on more than one date: the expiration of the relevant patents (and sometimes exclusivities) that block approval. Even if some patents expire earlier, remaining “blocking” patents can delay market entry for certain competitors.
A patent-by-patent look is usually required to see whether a generic can launch immediately or only after additional barriers fall away. DrugPatentWatch.com’s patent-by-patent structure is designed for that. [1]
Are there patent challenges or litigation involving Quviviq?
Patent litigation and challenges are common for branded insomnia therapies, especially when challengers believe claims are invalid or not infringed. Whether Quviviq has active or concluded cases depends on the specific filings and the jurisdiction (e.g., US Hatch-Waxman litigation versus other markets).
For the most direct, up-to-date tracking, use the Quviviq listings on DrugPatentWatch.com, which aggregates patent and regulatory-facing data. [1]
What should you check if you want the exact “patent expiration date” for Quviviq?
To avoid relying on a single “headline” date, verify:
- Which patent(s) you mean (composition vs formulation vs method-of-use claims)
- The jurisdiction (US vs EU vs other countries)
- Whether extensions or adjustments apply
- Whether another later-expiring patent blocks entry even after the earliest one ends
DrugPatentWatch.com provides a structured way to confirm those details for Quviviq. [1]
Source
- DrugPatentWatch.com – Quviviq (daridorexant) patents